RECENT ADVANCES IN ALZHEIMER'S DISEASE: CAUSES AND TREATMENT

Abstract

Alzheimer’s disease (AD) is a destructive neurodegenerative disorder characterized by progressive memory defeat and impairment in behavior, language, and visuospatial skills. Neuropsychiatric symptoms such as apathy, depression, aggression, agitation, sleep disruption, and psychosis are now recognized as core symptoms of AD that are expressed to varying degrees throughout the course of disease. The neuro pathological features of AD comprise extracellular senile plaques constituted of β-amyloid (Aβ) pledges, intracellular neurofibrillary tangles (NFTs), and cerebral atrophy; others include apolipoprotein E, oxidative stress, mitochondrial dysfunction and cholinergic hypothesis. Anti-amyloid therapy is available for the treatment of Alzheimer’s disease, others are anticholinergic therapy, and therapy for mitochondrial dysfunction, γ-secretase inhibitors (GSI) and modulators (GSM), 𝛽-secretase (BACE1) inhibitors, Glial modulating drugs includes RAGE receptor antagonists, TNF-α antagonists, neuroprotective drugs such as antioxidants, phosphodiesterase inhibitors, PPARγ agonists, and anti-tau or tau modulators like microtubule stabilizers, kinase inhibitors. This review includes discussion on neurobiological mechanisms and newly developed compounds which have lesser side effects and are proving more efficient for treatment of Alzheimer’s disease. 

Authors and Affiliations

Kiranjit Kaur, Rajneet Kaur, Manjinder Kaur

Keywords

Related Articles

AB-FUBINACA, A SYNTHETIC CANNABINOID IN “FUNKY GREEN STUFF™”

Objective: The objective of this research was to isolate and identify any potential synthetic cannabinoids disguised in the commercially available claimed-to-be herbal scent, known as “Funky Green Stuff™”.Methods:...

PROTECTIVE ROLE OF N-PROPYL GALLATE ON DOCETAXEL-INDUCED CHANGES IN CHOLESTEROL PROFILE

Objectives: The aim of the study is to evaluate the protective effects of n-propyl gallate on docetaxel-induced changes in cholesterol profile in vitro.Methods: Goat blood was used as the lipid source for the model. In t...

THE METAL COMPLEXES OF 1-(PHENYLAMINO)-4, 4, 6-TRIMETHYL-3, 4-DIHYDROPYRIMIDINE-2-(1H)-THIONE: PREPARATION, PHYSICAL, SPECTROSCOPIC STUDIES AND ANTIBACTERIAL PROPERTIES

Objective: The metal complexes of 1-(Phenylamino)-4, 4, 6-trimethyl-3, 4-dihydropyrimidine-2-(1H)-thione: preparation, physical and spectroscopic studies and preliminary antibacterial properties.Methods: Complexes of bid...

SUBCLINICAL HYPOTHYROIDISM IN PREGNANCY; IS THERE A NEED FOR PHARMACOLOGICAL INTERVENTION?

Objective: To find the prevalence of subclinical hypothyroidism in the first trimester of pregnancy and to compare the maternal and perinatal outcome in them with euthyroid mothers.Methods: The present study was a prospe...

SUPPLEMENTATION OF CALCIUM AND SELENIUM AGAINST CADMIUM INDUCED BIOACCUMULATION IN SELECTED TISSUES OF FRESH WATER FISH, OREOCHROMIS MOSSAMBICUS

Objective: Cadmium (Cd) is one of the most hazardous heavy metals in aquatic environments and could threaten aquatic organisms including fish. The present study was carried out to know the protective effects of calcium (...

Download PDF file
  • EP ID EP577835
  • DOI -
  • Views 42
  • Downloads 0

How To Cite

Kiranjit Kaur, Rajneet Kaur, Manjinder Kaur (2016). RECENT ADVANCES IN ALZHEIMER'S DISEASE: CAUSES AND TREATMENT. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2), 8-15. https://europub.co.uk/articles/-A-577835